Shareholders who hold equity interests in Companies listed on SIX have the legal requirement of disclosing their equity interests whenever their total holdings reach the level of 3%, 5%, 10%, 15%, 20%, 25%, 33 1/3%, 50% and 66 2/3% or fall beneath these levels.
All applicable shareholdings need to be reported to SIX. With the following link you will directly get to the announcements of Cosmo Pharmaceuticals on the SIX platform.